ライフサイエンスコーパス: review board

1 This study was approved by the institutional review board.

2 l animal studies committee and institutional review board.

3 iant study was approved by the institutional review board.

4 iant study was approved by the institutional review board.

5 consent under approval of the institutional review board.

6 tive study was approved by the institutional review board.

7 trol study was approved by the institutional review board.

8 tive study was approved by the institutional review board.

9 with HIPAA and approved by the institutional review board.

10 iant study was approved by the institutional review board.

11 mpliant study was exempted from the internal review board.

12 compliant and approved by the institutional review board.

13 a-analysis was approved by the institutional review board.

14 tive study was approved by the institutional review board.

15 hort study was approved by the institutional review board.

16 This study was approved by the institutional review board.

17 tudy was approved by the local institutional review board.

18 tive study was approved by the institutional review board.

19 e United States under the new National Liver Review Board.

20 The study was approved by the institutional review board.

21 was approved by the university institutional review board.

22 care and use committee and the institutional review board.

23 hed tribal health research and institutional review boards.

24 After approval by the institutional review board, 1,022 LNs in the PET/CT examinations of 14

25 -matched study approved by the institutional review board, 16 patients who tested positive for severe

26 ve study, which was approved by the internal review board, a total of 126 participants with obesity w

27 rch was approved by the McGill institutional review board (A04-M47-12B).

28 This study was approved by the institutional review board and all participants gave informed consent.

29 This study was approved by the institutional review board and by national government authorities.

30 This study was approved by the institutional review board and compliant with HIPAA and included BCSC

31 onal study was approved by the institutional review board and compliant with HIPAA.

32 tive study was approved by the institutional review board and compliant with HIPAA.

33 tive study was approved by the institutional review board and compliant with HIPAA.

34 This study was approved by the institutional review board and compliant with HIPAA.

35 This study was approved by the institutional review board and complied with HIPAA.

36 ementation were overseen by an institutional review board and conformed to HIPAA guidelines on patien

37 tive study was approved by the institutional review board and included 38 patients with hepatocellula

38 Materials and Methods Institutional review board and informed consent were waived for this s

39 tional Military Medical Center institutional review board and is compliant with HIPAA guidelines.

40 tional Military Medical Center institutional review board and is compliant with HIPAA guidelines.

41 The study was approved by the institutional review board and is Health Insurance Portability and Acc

42 Materials and Methods Institutional review board and local ethics committee approval and wri

43 s compliant with HIPAA and the institutional review board and required written consent from the parti

44 stem cells was approved by the institutional review board and the stem cell research oversight commit

45 hort study was approved by the institutional review board and was compliant with HIPAA.

46 spective study approved by the institutional review board and was HIPAA compliant with waiver of info

47 The study was approved by the institutional review board and written informed consent with HIPAA aut

48 tive study was approved by the institutional review boards and compliant with HIPAA.

49 ablishing common protocols for institutional review boards and data sharing, creating protocols for r

50 y protocol was approved by the institutional review boards and was HIPAA compliant.

51 The study was approved by the institutional review board, and all participants gave informed consent

52 This study was approved by the institutional review board, and all participants gave written informed

53 This study was approved by the institutional review board, and all subjects gave signed informed cons

54 tudy was approved by the local institutional review board, and informed consent was obtained from all

55 prospective study was approved by the ethics review board, and informed consent was obtained.

56 tive study was approved by the institutional review board, and informed consent was waived.

57 tive study was approved by the institutional review board, and the requirement for informed consent w

58 tive study was approved by the institutional review board, and the requirement to obtain informed con

59 tive study was approved by the institutional review board, and the requirement to obtain informed con

60 etrospective study was approved by an ethics review board, and the requirement to obtain informed wri

61 This study was approved by the institutional review board, and written informed consent was obtained

62 tive study was approved by the institutional review board, and written informed consent was obtained.

63 onal study was approved by the institutional review boards, and all participants gave informed consen

64 terials and Methods This is an institutional review board- and U.S. Food and Drug Administration-appr

65 esignation and is exempt from Human Subjects Review Board approval (11-DRDS-NR03).

66 and Methods The study received institutional review board approval and all patients gave written info

67 his prospective study received institutional review board approval and fully complied with HIPAA regu

68 Materials and Methods With institutional review board approval and Health Insurance Portability a

69 aterials and Methods Following institutional review board approval and informed consent, 26 subjects

70 After institutional review board approval and informed consent, consecutive

71 Institutional review board approval and informed patient consent were

72 als and Methods This study had institutional review board approval and was HIPAA compliant.

73 Materials and Methods Institutional review board approval and written informed consent from

74 Materials and Methods Institutional review board approval and written informed consent were

75 Institutional review board approval and written informed consent were

76 Materials and Methods Institutional review board approval and written informed consent were

77 Materials and Methods Institutional review board approval and written informed consent were

78 tudy was HIPAA compliant, with institutional review board approval and written informed consent.

79 Materials and Methods Institutional review board approval and written informed patient conse

80 ctal liver metastases, whereas institutional review board approval is required before glass microsphe

81 Methods In accordance with the institutional review board approval obtained at the two participating

82 tional new drug submission and institutional review board approval standards.

83 ve analysis was performed with institutional review board approval using data collected from diabetic

84 Materials and Methods Institutional review board approval was given and patient consent was

85 ation was accessed; therefore, institutional review board approval was not sought.

86 Institutional review board approval was obtained and informed consent

87 Materials and Methods Institutional review board approval was obtained and informed consent

88 Materials and Methods Institutional review board approval was obtained and the requirement f

89 Materials and Methods Institutional review board approval was obtained for active or passive

90 Institutional review board approval was obtained for this Health Insur

91 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

92 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

93 Materials and Methods Institutional review board approval was obtained for this HIPAA-compli

94 Materials and Methods Institutional review board approval was obtained for this prospective

95 Institutional review board approval was obtained for this prospective

96 Materials and Methods Institutional review board approval was obtained for this retrospectiv

97 Materials and Methods Institutional review board approval was obtained for this study; all p

98 Materials and Methods Institutional review board approval was obtained from Leipzig Universi

99 Materials and Methods Institutional review board approval was obtained with waiver of consen

100 Institutional review board approval was obtained, and all recruited su

101 Materials and Methods Institutional review board approval was obtained, and informed consent

102 Materials and Methods Institutional review board approval was obtained, and patient consent

103 Materials and Methods Institutional review board approval was obtained, and the requirement

104 Materials and Methods Institutional review board approval was obtained, with waiver of infor

105 Materials and Methods Review board approval was obtained, with waiver of infor

106 Institutional review board approval was obtained, with waiver of the n

107 iver of informed consent after institutional review board approval was obtained.

108 Materials and Methods Institutional review board approval was obtained.

109 Institutional review board approval was obtained.

110 in U.S. Materials and Methods Institutional review board approval was waived, as the study used publ

111 HISTORY: Materials and Methods Institutional review board approval was waived, as the study used publ

112 After institutional review board approval with a waiver of informed consent

113 nd Methods This study received institutional review board approval with waiver of consent.

114 nter HIPAA-compliant study had institutional review board approval, and all participants gave written

115 als and Methods This study had institutional review board approval, and informed consent was obtained

116 This HIPAA-compliant study had institutional review board approval, and informed consent was obtained

117 nd Methods This study received institutional review board approval, and patients gave informed consen

118 and Methods The study received institutional review board approval, and patients in the CLQ cohort pr

119 This HIPAA-compliant study had institutional review board approval, and the need for informed consent

120 After institutional review board approval, participants were enrolled prospe

121 taining antemortem consent and institutional review board approval, the authors compared postmortem n

122 With institutional review board approval, this study retrospectively compar

123 hese include delays in gaining Institutional Review Board approval, timeliness of budget and contract

124 With institutional review board approval, we searched our prospectively acq

125 s retrospective study received institutional review board approval, with a waiver of the HIPAA requir

126 aterials and Methods Following institutional review board approval, with waiver of consent and with H

127 ectional study was exempt from institutional review board approval.

128 e database were evaluated with institutional review board approval.

129 eers with informed consent and institutional review board approval.

130 pliant study was exempted from institutional review board approval.

131 lectronic health records after institutional review board approval.

132 tive study was completed after institutional review board approval.

133 s This retrospective study had institutional review board approval; written informed consent was obta

134 als and Methods This study was institutional review board approved and HIPAA compliant.

135 This study was institutional review board approved and HIPAA compliant.

136 This retrospective study was institutional review board approved and HIPAA compliant; informed cons

137 tom experiment, followed by an institutional review board approved clinical intervention, to evaluate

138 An Institutional Review Board approved retrospective search of University

139 The institutional review board approved the study and all participants pro

140 The local institutional review board approved the study, and all participants ga

141 Materials and Methods The institutional review board approved the study.

142 Materials and Methods The institutional review board approved this cross-sectional study.

143 aterials and Methods The local institutional review board approved this HIPAA-compliant retrospective

144 Materials and Methods The institutional review board approved this prospective Health Insurance

145 Materials and Methods The institutional review board approved this prospective hypotheses-genera

146 Materials and Methods The institutional review board approved this retrospective cohort study, w

147 Materials and Methods The institutional review board approved this retrospective study and infor

148 Materials and Methods An institutional review board approved this retrospective study and waive

149 The institutional review board approved this retrospective study of 403 pa

150 This institutional review board approved this retrospective study, and waiv

151 Materials and Methods Institutional review board approved this retrospective study, with wai

152 Materials and Methods The institutional review board approved this retrospective study, with wai

153 The institutional review board approved this study and waived the need for

154 Materials and Methods The institutional review board approved this study.

155 This study was retrospective, institutional review board approved, and HIPAA compliant.

156 This retrospective study was Institutional Review Board approved, and informed consent was waived.

157 Materials and Methods This institutional review board approved, HIPAA-compliant retrospective rev

158 In this institutional review board approved-study, a total of 1830 posteroante

159 is study was HIPAA compliant and institution review board approved.

160 ompliant prospective study was institutional review board approved.

161 This retrospective study was institutional review board approved.

162 Materials and Methods Institutional review boards approved this HIPAA-compliant protocol, an

163 als and Methods The respective institutional review boards approved this HIPAA-compliant study and wa

164 rials and Methods The relevant institutional review boards approved this HIPAA-compliant study, with

165 The applicable institutional review boards approved this study, and all participants

166 ods This prospective study was institutional review board- approved and HIPAA compliant.

167 In this institutional review board-approved and Health Insurance Portability a

168 Materials and Methods In this institutional review board-approved and HIPAA-compliant protocol, 408

169 aterials and Methods This was an intuitional review board-approved and HIPAA-compliant retrospective

170 erials and Methods This was an institutional review board-approved and HIPAA-compliant retrospective

171 e enrolled in this prospective institutional review board-approved and HIPAA-compliant study between

172 Materials and Methods This institutional review board-approved and HIPAA-compliant study was a 6-

173 erials and Methods This was an institutional review board-approved and HIPAA-compliant study.

174 were included randomly in our institutional review board-approved and retrospective study.

175 e patients were enrolled in an institutional review board-approved clinical trial and randomized to a

176 multicenter, HIPAA-compliant, institutional review board-approved clinical trial was performed by ex

177 node resection (MLNR) under an Institutional Review Board-approved common protocol from 1992 to 2014.

178 Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective anal

179 Materials and Methods This institutional review board-approved HIPAA-compliant retrospective stud

180 Materials and Methods For this institutional review board-approved HIPAA-compliant retrospective stud

181 Materials and Methods In this institutional review board-approved HIPAA-compliant retrospective stud

182 = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11)C-MET PET/CT.

183 = 19) and NHL (n = 2) onto the Institutional Review Board-approved investigation of (11)C-MET PET/CT.

184 e prospectively enrolled on an institutional review board-approved investigational study of (11)C-met

185 An institutional review board-approved multicenter prospective registry w

186 In an institutional review board-approved multicenter study, we carried out

187 es data were obtained from our institutional review board-approved myeloma database.

188 Methods: In an Institutional Review Board-approved pilot study, the initial clinical

189 hods For this HIPAA-compliant, institutional review board-approved prospective blinded pilot study, p

190 metastases were enrolled in an institutional review board-approved prospective clinical trial.

191 metastases were enrolled in an Institutional Review Board-approved prospective clinical trial.

192 In this Institutional Review Board-approved prospective cohort study, 20 subje

193 Materials and Methods In this institutional review board-approved prospective observational study (2

194 Methods: In this institutional review board-approved prospective single-institution stu

195 erials and Methods This was an institutional review board-approved prospective study in 29 patients (

196 ethods In this HIPAA-compliant institutional review board-approved prospective study in which all sub

197 Materials and Methods In this institutional review board-approved prospective study, 27 patients wit

198 Materials and Methods In this institutional review board-approved prospective study, 45 participants

199 In this institutional review board-approved prospective study, a woman with tr

200 gh the Basque Biobank under an institutional review board-approved protocol.

201 and 252 controls) according to institutional review board-approved protocols and shipped to a central

202 thods In this HIPAA-compliant, institutional review board-approved retrospective cohort study, an ins

203 consisted of a HIPAA-compliant institutional review board-approved retrospective review of data in 16

204 Materials and Methods In this institutional review board-approved retrospective review of prospectiv

205 Materials and Methods An institutional review board-approved retrospective review was performed

206 Methods This HIPAA-compliant, institutional review board-approved retrospective study included 108 p

207 d Methods This HIPAA-compliant institutional review board-approved retrospective study included 159 p

208 This institutional review board-approved retrospective study included 315 a

209 Methods This HIPAA-compliant, institutional review board-approved retrospective study included 51 pa

210 Methods: In this Institutional Review Board-approved retrospective study, our Health Ca

211 In this institutional review board-approved retrospective study, subjects were

212 Materials and Methods This institutional review board-approved retrospective study, with waived i

213 erials and Methods This was an institutional review board-approved retrospective study, with waiver o

214 Accountability Act-compliant, institutional review board-approved retrospective study.

215 This was a HIPAA-compliant, institutional review board-approved retrospective study.

216 2010 to October 2012 for this institutional review board-approved study after they provided written

217 s prospective HIPAA-compliant, institutional review board-approved study between April 2012 and Novem

218 This institutional review board-approved study from June 2007 to December 2

219 Materials and Methods This institutional review board-approved study included 125 women with inva

220 and Methods This retrospective institutional review board-approved study included 24 patients with pr

221 Methods This HIPAA-compliant, institutional review board-approved study measured the performance of

222 ethods: This was a prospective institutional review board-approved study of 90 patients with document

223 Methods: This is a prospective institutional review board-approved study of 90 patients with document

224 This was an institutional review board-approved study of adult patients discharged

225 We performed an institutional review board-approved study of healthy NMDE secretion af

226 and Methods This retrospective institutional review board-approved study received a waiver of informe

227 retrospective HIPAA-compliant institutional review board-approved study was exempt from informed con

228 Methods This HIPAA-compliant, institutional review board-approved study was performed at a tertiary

229 prospective, HIPAA-compliant, institutional review board-approved study was performed by using the s

230 Methods In this retrospective, institutional review board-approved study, 120 patients who underwent

231 etrospective, HIPAA-compliant, institutional review board-approved study, 136 consecutive patients (9

232 ingle-center, HIPAA-compliant, institutional review board-approved study, 157 patients (86 men and 71

233 Materials and Methods In this institutional review board-approved study, 20 patients with chronic th

234 Methods In this retrospective, institutional review board-approved study, 33 patients who underwent a

235 Methods In this retrospective, institutional review board-approved study, 41 pediatric patients (age

236 In this institutional review board-approved study, a stroke database of 962 ca

237 thods In this HIPAA-compliant, institutional review board-approved study, all patients with ADPKD pro

238 Materials and Methods In this institutional review board-approved study, all unenhanced DE head CT e

239 d Methods: In this prospective institutional review board-approved study, both MUSE DWI and single-sh

240 ods This was a HIPAA-compliant institutional review board-approved study, with informed consent from

241 ncluded in this retrospective, institutional review board-approved study.

242 itant CT were enrolled in this institutional review board-approved study.

243 ent prior to inclusion in this institutional review board-approved study.

244 pared in this HIPAA-compliant, institutional review board-approved study.

245 vided informed consent in this institutional review board-approved study.

246 vided informed consent in this institutional review board-approved study.

247 ive OCT study is a prospective Institutional Review Board-approved study.

248 Study is a prospective cohort, institutional review board-approved study.

249 rolled in this cross-sectional institutional review board-approved study.

250 This study was institutional review board-approved with waivers of informed consent.

251 This was a retrospective, institutional review board-approved, Health Insurance Portability and

252 nd Methods In this binational, institutional review board-approved, HIPAA-compliant prospective study

253 er 2011 to September 2012 with institutional review board-approved, HIPAA-compliant protocols.

254 tireader, multi-institutional, institutional review board-approved, HIPAA-compliant retrospective ana

255 Materials and Methods This institutional review board-approved, HIPAA-compliant retrospective stu

256 Materials and Methods This institutional review board-approved, HIPAA-compliant study included 14

257 Materials and Methods In this institutional review board-approved, HIPAA-compliant study, 58 patient

258 In this institutional review board-approved, HIPAA-compliant study, a silicon

259 hods This was a retrospective, institutional review board-approved, HIPAA-compliant study.

260 In an institutional review board-approved, HIPAA-compliant, prospective stud

261 Materials and Methods This institutional review board-approved, HIPAA-compliant, retrospective st

262 Materials and Methods This institutional review board-approved, HIPAA-compliant, retrospective st

263 In this institutional review board-approved, informed consent-waived, HIPAA-co

264 with DME were included in this institutional review board-approved, prospective longitudinal study.

265 erials and Methods This was an institutional review board-approved, prospectively conducted (written

266 This is an Institutional Review Board-approved, retrospective study.

267 ials and Methods SIESTA was an institutional review board-approved, single-center, prospective, rando

268 tive HIPAA-compliant study was institutional review board-approved.

269 00002663) were approved by the Institutional Review Board at Memorial Sloan Kettering Cancer Center,

270 tions should be reviewed by an institutional review board, but may not require patient-level informed

271 An institutional review board exemption and a waiver for informed consent

272 Institutional review board exemptions were granted prior to the collec

273 te response, assessed by a central pathology review board following European Organisation for Researc

274 obtained from the centralized institutional review board for this prospective single-arm study, and

275 tive study was approved by the institutional review board; informed consent was obtained from all pat

276 s research was approved by the institutional review board (IRB) and was HIPAA compliant.

277 Institutional review board (IRB) approval was obtained for this retros

278 ted four prototypes through an institutional review board (IRB)-approved clinical trial that involved

279 r (TRD) who participated in an Institutional Review Board (IRB)-approved randomised double-blind tria

280 We conducted an institutional review board-IRB-approved retrospective review of advanc

281 ethical review of research by institutional review boards (IRBs) due to the rush to enter the disast

282 ality and effectiveness of the institutional review boards (IRBs) responsible for overseeing research

283 Methods The study was approved by the local review board (NL42888.029.13).

284 HWCS) has been approved by the Institutional Review Board of the Mexican Social Security Institute (1

285 for the study was obtained from the ethical review board of the Netherlands Association for Medical

286 records review approved by the institutional review board of the University Health Network, Toronto.

287 The study was approved by the institutional review board of Thomas Jefferson University Hospital.

288 Materials and Methods The institutional review boards of all participating centers approved this

289 Materials and Methods The institutional review boards of each center approved this retrospective

290 Materials and Methods The institutional review boards of the four participating centers approved

291 t protocol was approved by the institutional review boards of the participating centers.

292 nography Materials and Methods Institutional review board permission was obtained to use deidentified

293 tients were collected under an institutional review board protocol 2 hours after portal reperfusion,

294 iew by the Columbia University Institutional Review Board, Protocol ID# AAAO3003.

295 ed research, investigators and Institutional Review Boards should consider a deferred consent process

296 tive study was approved by the institutional review board; the requirement to obtain informed consent

297 The institutional review board waived the need for consent.

298 The institutional review board waived the requirement for informed consent

299 re exempted from review by the institutional review board, which consisted of 1007 posteroanterior ch

300 tive study was approved by the institutional review board, which waived the requirement for informed